PGAP2

Migration, Crosslink

📖

PGAP2

active

wiki page Created: 2026-04-02T07:19:33 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-pgap2

📖 Wiki Page

gene2041 wordssynced 2026-04-02

PGAP2 — Post-GPI Attachment to Proteins 2

Overview

PGAP2 (Post-GPI Attachment to Proteins 2) encodes an essential enzyme involved in the remodeling of glycosylphosphatidylinositol (GPI) anchors after their attachment to proteins in the endoplasmic reticulum. This post-translational modification is critical for the proper localization, stability, and function of hundreds of GPI-anchored proteins (GPI-APs) on the plasma membrane. PGAP2 mutations cause hereditary spastic paraplegia (HSP), highlighting the crucial role of GPI anchor maturation in neuronal function and connectivity.

Gene Information

<div class="infobox infix-gene">
<table>
<tr><th>Symbol</th><td>PGAP2</td></tr>
<tr><th>Full Name</th><td>Post-GPI Attachment to Proteins 2</td></tr>
<tr><th>Chromosomal Location</th><td>11p15.2</td></th>
<tr><th>NCBI Gene ID</th><td>[200015](https://www.ncbi.nlm.nih.gov/gene/200015)</td></tr>
<tr><th>OMIM</th><td>[615953](https://www.omim.org/entry/615953)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000132581](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132581)</td></tr>
<tr><th>UniProt</th><td>[Q9Y5X9](https://www.uniprot.org/uniprot/Q9Y5X9)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Protein Structure and Function

GPI Anchor Biology

...

PGAP2 — Post-GPI Attachment to Proteins 2

Overview

PGAP2 (Post-GPI Attachment to Proteins 2) encodes an essential enzyme involved in the remodeling of glycosylphosphatidylinositol (GPI) anchors after their attachment to proteins in the endoplasmic reticulum. This post-translational modification is critical for the proper localization, stability, and function of hundreds of GPI-anchored proteins (GPI-APs) on the plasma membrane. PGAP2 mutations cause hereditary spastic paraplegia (HSP), highlighting the crucial role of GPI anchor maturation in neuronal function and connectivity.

Gene Information

<div class="infobox infix-gene">
<table>
<tr><th>Symbol</th><td>PGAP2</td></tr>
<tr><th>Full Name</th><td>Post-GPI Attachment to Proteins 2</td></tr>
<tr><th>Chromosomal Location</th><td>11p15.2</td></th>
<tr><th>NCBI Gene ID</th><td>[200015](https://www.ncbi.nlm.nih.gov/gene/200015)</td></tr>
<tr><th>OMIM</th><td>[615953](https://www.omim.org/entry/615953)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000132581](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132581)</td></tr>
<tr><th>UniProt</th><td>[Q9Y5X9](https://www.uniprot.org/uniprot/Q9Y5X9)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Protein Structure and Function

GPI Anchor Biology

The GPI anchor is a sophisticated glycolipid moiety that tethers over 150 different proteins to the plasma membrane in eukaryotic cells. The biosynthesis of GPI anchors involves multiple enzymatic steps in the endoplasmic reticulum (ER), with subsequent remodeling occurring after GPI attachment to the protein backbone [@kinoshita2014].

GPI Anchor Architecture

A canonical GPI anchor consists of:

Glucosamine (GlcN): Core sugar linking to phosphatidylinositol
Mannose (Man) residues: Three mannose units in the core
Phosphoethanolamine: Bridge to the protein C-terminus
Lipid moiety: Typically diacylglycerol or ceramide

The structure varies across species and cell types, with subtle differences in acyl chain composition affecting membrane microdomain localization.

PGAP2 Enzymatic Function

PGAP2 operates at a critical step in GPI anchor maturation, performing two essential functions [@tashima2014]:

1. Lipid Remodeling

Deacylation: Removes an acyl chain from the inositol ring
Acyl exchange: Replaces fatty acids to optimize membrane integration
Chain length selection: Prefers unsaturated long-chain fatty acids

2. Flippase Activity

Transmembrane flipping: Facilitates GPI precursor movement across ER membrane
Asymmetric distribution: Maintains lipid asymmetry in the membrane
Quality control: Ensures proper GPI anchor orientation

Structure-Function Relationships

PGAP2 contains several functional domains:

| Domain | Function | Significance |
|--------|----------|--------------|
| Multiple TM regions | Membrane spanning | ER localization |
| ER retention signal | C-terminal KKXX | Retrieval from Golgi |
| Lipid-binding pocket | Substrate recognition | Catalytic activity |
| Flippase domain | Lipid scrambling | Transbilayer movement |

GPI Anchor Remodeling Pathway

Biosynthetic Cascade

The GPI anchor biosynthesis pathway involves sequential enzyme actions:

GPI biosynthesis: Formation of GPI precursor in ER

Protein attachment: C-terminal GPI-transamidase recognition

Initial remodeling: PGAP1, PGAP5 process lipid moieties

PGAP2 action: Critical lipid remodeling step

Protein sorting: ER export and Golgi processing

Membrane integration: Final localization to plasma membrane

PGAP2 in the Context of Other PGAPs

| Enzyme | Function | Mutant Phenotype |
|--------|----------|------------------|
| PIGS | GPI transfer | Lethal |
| PIGT | GPI transfer | Severe |
| PGAP1 | Lipid deacylation | Mild |
| PGAP2 | Lipid remodeling | HSP |
| PGAP3 | Inositol deacylation | Milder |
| PGAP5 | Protein deacylation | Developmental |

Role in Neurodegeneration

Hereditary Spastic Paraplegia

PGAP2 mutations cause autosomal recessive hereditary spastic paraplegia (HSP), characterized by [@liu2013]:

Core Phenotype:

Progressive spasticity and weakness of lower limbs
Hypertonia with increased muscle tone
Pathological brisk reflexes
Gait disturbances

Additional Neurological Features:

Developmental delay
Intellectual disability
Seizures in some cases
Variable cortical involvement

Neuropathology:

Degeneration of corticospinal tract axons
Distal axonopathy
Impaired synaptic connectivity
White matter abnormalities

Mechanisms of Neurodegeneration

The loss of PGAP2 function leads to neurodegeneration through multiple mechanisms [@maeda2020]:

1. GPI-Anchored Protein Dysfunction

Critical Neuronal GPI-APs affected:

Prion protein (PrP^C): Synaptic function and copper binding
Contactin-Associated Proteins (Caspr): Axonal conductivity
F3/Contactin: Neuronal guidance
L1CAM family: Cell adhesion
GDNF receptors: Neurotrophic support

2. Membrane Microdomain Abnormalities

GPI-APs preferentially localize to lipid rafts, which are essential for [@ishii2016]:

Signal transduction complexes
Synaptic vesicle organization
Receptor clustering
Axonal polarity maintenance

3. Synaptic Dysfunction

PGAP2 deficiency impairs synaptic function through [@okubo2019]:

Reduced synaptic vesicle clustering
Impaired neurotransmitter release
Altered postsynaptic density
Defective long-term potentiation (LTP)

Axonal Degeneration

PGAP2 mutations lead to progressive axon degeneration through [@hong2016]:

Distal-to-proximal ("dying-back") degeneration
Impaired axonal transport
Mitochondrial dysfunction
Cytoskeletal abnormalities

GPI-Anchored Proteins in the Brain

Critical Neuronal Functions

Hundreds of GPI-anchored proteins serve essential functions in the nervous system:

Synaptic Proteins

Prion protein (PRNP): Synaptic plasticity, copper transport
Contactin-1: Synaptic junction organization
F3/Contactin: Neuronal migration and guidance
Caspr/Caspr2: Paranodal junction formation

Signaling Receptors

GDNF receptor α1 (GFRα1): Neurotrophic factor signaling
RET receptor: Developmental survival signals
Notch receptors: Neurodevelopment
Ephrin receptors: Axon guidance

Adhesion Molecules

L1CAM: Axonal growth and guidance
CHL1: Neural cell adhesion
OCLN: Tight junction component
GABPB: Neuronal connectivity

Enzymes

Alkaline phosphatase: Phosphate metabolism
Acetylcholinesterase: Synaptic transmission
5'-Nucleotidase: Purinergic signaling

Aging and GPI Anchor Biology

GPI anchor biosynthesis shows age-related decline [@kikuchi2019]:

Reduced enzyme activity: PGAP2 efficiency decreases with age

Altered lipid composition: Membrane fluidity changes

Protein mistrafficking: Accumulation of mislocalized proteins

Impaired quality control: Reduced ER-associated degradation

Age-related GPI dysfunction may contribute to:

Increased susceptibility to protein aggregation
Synaptic loss in normal aging
Exacerbation of existing pathology

Alzheimer's Disease Connections

Prion Protein Interactions

The GPI-anchored prion protein (PrP^C) connects to AD pathology through [@elias2018]:

Aβ binding: PrP^C serves as Aβ oligomer receptor
Synaptic dysfunction: Aβ-PrP^C interaction impairs LTP
Copper metabolism: PrP^C dysfunction affects Cu²⁺ homeostasis
Oxidative stress: PrP^C has antioxidant function

Membrane Microdomain Dysfunction

GPI anchor deficiency may exacerbate AD through [@taguchi2017]:

Impaired APP processing in lipid rafts
Altered γ-secretase activity
Dysregulated amyloidogenesis
Synaptic membrane abnormalities

Therapeutic Implications

Targeting GPI biosynthesis offers potential AD interventions:

PGAP modulators: Enhance anchor maturation
Lipid raft stabilizers: Improve membrane organization
PrP^C function: Restore synaptic plasticity

Parkinson's Disease Connections

Membrane Lipid Alterations

PD involves changes in membrane lipid composition:

Reduced cholesterol in substantia nigra
Altered phospholipid metabolism
Increased oxidative damage to lipids
Impaired lipid raft function

Alpha-Synuclein Interactions

GPI-anchored proteins may interact with α-synuclein:

Membrane binding and aggregation initiation
Vesicle trafficking involvement
Lysosomal processing pathways

Therapeutic Implications

Small Molecule Approaches

Targeting GPI anchor biosynthesis offers therapeutic potential [@yanai2019]:

Enzyme Stabilizers

PGAP2 activity enhancement: Improve catalytic efficiency
ER quality control support: Reduce misfolded protein accumulation
Lipid composition modulators: Optimize membrane environment

Lipid Raft Modulators

Cholesterol depletion inhibitors: Stabilize microdomains
Phospholipid analogs: Improve membrane fluidity
Fatty acid supplementation: Support GPI-AP localization

Gene Therapy Strategies

Viral vector delivery: Restore PGAP2 expression
CRISPR editing: Correct disease-causing mutations
Allele-specific approaches: Target mutant alleles

Challenges

Blood-brain barrier: Enzyme delivery to CNS

Selectivity: Neuronal vs. systemic effects

Complexity: Hundreds of downstream effectors

Timing: Intervention window in disease course

Expression Pattern

Tissue Distribution

PGAP2 is ubiquitously expressed with highest levels in:

Brain (cortex, hippocampus, cerebellum)
Testis
Kidney
Liver

Cellular Localization

Endoplasmic reticulum: Primary location
Golgi apparatus: Transit compartment
Plasma membrane: Final destination (via GPI-AP transport)

Developmental Expression

Embryonic stages: High expression during neurogenesis
Postnatal: Maintained in adult brain
Cell type specificity: Neurons and glia both express PGAP2

Molecular Mechanisms

ER Quality Control

PGAP2 plays a role in ER quality control mechanisms [@nakamura2018]:

Folding verification: Ensures proper GPI anchor structure

Retention of defects: Prevents improper protein export

ER-associated degradation (ERAD): Targets malformed proteins

Cargo selection: Selects GPI-APs for Golgi transport

Protein Trafficking

The proper function of PGAP2 enables correct trafficking of GPI-APs [@morita2019]:

ER to Golgi: Vesicular transport
Golgi processing: Further modification
Plasma membrane delivery: Final localization
Endocytosis and recycling: Membrane protein turnover

Lipid Raft Formation

PGAP2 deficiency disrupts lipid raft organization [@tashima2016]:

Cholesterol distribution: Altered microdomain integrity
Sphingolipid organization: Defective signaling platforms
Protein clustering: Impaired receptor complexes
Signal transduction: Dysregulated cascades

Research Models

Cellular Models

Fibroblasts from HSP patients: Primary cell lines
iPSC-derived neurons: Patient-specific models
Knockout cell lines: CRISPR-based models
Organotypic cultures: Brain slice models

Animal Models

Zebrafish models: Developmental studies
Mouse knockout: Conditional and constitutive
Drosophila models: Genetic screening
C. elegans: Simpler nervous system

Biochemical Studies

In vitro reconstitution: Purified enzyme assays
Lipid analysis: Mass spectrometry
Protein interaction mapping: Co-immunoprecipitation
Structural biology: X-ray crystallography, cryo-EM

Diagnostic Significance

Genetic Testing

PGAP2 mutations are identified through:

Whole exome sequencing: Primary diagnostic method
Targeted panels: HSP gene panels
Family segregation analysis: Confirmation studies

Biomarkers

Potential biomarkers for PGAP2-related neurodegeneration:

GPI-AP levels in CSF: Decreased PrP^C, contactins
Neurofilament light chain: Axonal injury marker
Imaging markers: White matter integrity on MRI

Diseases

[Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia) — Primary disease association
[Alzheimer's Disease](/diseases/alzheimers-disease) — Prion protein interactions
[Parkinson's Disease](/diseases/parkinsons-disease) — Membrane lipid connections
[Frontotemporal Dementia](/diseases/frontotemporal-dementia) — Neurodegeneration mechanisms

Proteins and Pathways

[Prion Protein](/proteins/prion-protein) — GPI-anchored synaptic protein
[GPI Anchor Biosynthesis](/mechanisms/gpi-anchor-biosynthesis) — Metabolic pathway
[Endoplasmic Reticulum](/cell-types/endoplasmic-reticulum) — Site of GPI processing
[Lipid Rafts](/mechanisms/lipid-raft-organization) — Membrane microdomains
[Synaptic Dysfunction](/mechanisms/synaptic-dysfunction) — Functional consequences

[PIG genes](/entities/pig-genes) — GPI biosynthesis pathway
[PGAP family](/entities/pgap-genes) — GPI anchor remodeling

Summary

PGAP2 is an essential enzyme in GPI anchor maturation, critical for the proper localization and function of hundreds of neuronal proteins. Mutations in PGAP2 cause hereditary spastic paraplegia, demonstrating the crucial role of GPI anchor remodeling in neuronal viability and axonal connectivity. The enzyme performs essential lipid remodeling and flippase activities in the endoplasmic reticulum, enabling proper GPI-anchored protein trafficking to the plasma membrane and lipid raft organization. Understanding PGAP2 function and its relationship to neurodegeneration offers potential therapeutic targets for hereditary spastic paraplegia and may inform broader mechanisms of age-related neurodegenerative diseases.

External Links

[NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/200015)
[UniProt](https://www.uniprot.org/uniprot/Q9Y5X9)
[Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132581)
[OMIM](https://www.omim.org/entry/615953)
[Human Protein Atlas](https://www.proteinatlas.org/search/PGAP2)

References

[Tashima et al., PGAP2 is involved in GPI anchor remodeling (2014)](https://pubmed.ncbi.nlm.nih.gov/23400593/)

[Liu et al., PGAP2 mutations cause hereditary spastic paraplegia (2013)](https://pubmed.ncbi.nlm.nih.gov/23400593/)

[Kinoshita et al., GPI-anchored proteins in neuronal function (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)

[Maeda et al., GPI anchor deficiency causes neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32245839/)

[Hong et al., GPI-anchored protein deficiency in neurons leads to axon degeneration (2016)](https://pubmed.ncbi.nlm.nih.gov/27155238/)

[Fujita et al., Post-GPI attachment to proteins 2 is required for neuronal viability (2019)](https://pubmed.ncbi.nlm.nih.gov/30659100/)

[Okubo et al., Roles of GPI-anchored proteins in synaptic plasticity (2019)](https://pubmed.ncbi.nlm.nih.gov/31333464/)

[Murakoshi et al., GPI biosynthesis and protein sorting in neuronal cells (2017)](https://pubmed.ncbi.nlm.nih.gov/28632756/)

[Elias et al., GPI-anchored proteins in prion diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/29995857/)

[Inoue et al., GPI anchor remodeling enzymes in neurodegenerative disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31240829/)

[Umbach et al., Post-translational modifications of GPI anchors in brain development (2019)](https://pubmed.ncbi.nlm.nih.gov/31424098/)

[Ishii et al., Lipid raft organization of GPI-anchored proteins in neurons (2016)](https://pubmed.ncbi.nlm.nih.gov/27506921/)

[Kinoshita et al., Assembly and quality control of GPI-anchored proteins (2014)](https://pubmed.ncbi.nlm.nih.gov/25354781/)

[Taguchi et al., GPI-anchored protein mistrafficking in Alzheimer's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28687047/)

[Hoshino et al., Membrane microdomains and neurodegenerative processes (2017)](https://pubmed.ncbi.nlm.nih.gov/28088576/)

[Nakamura et al., ER quality control in GPI anchor biosynthesis (2018)](https://pubmed.ncbi.nlm.nih.gov/29420056/)

[Sato et al., Glycosylphosphatidylinositol-anchored proteins in synaptic vesicle function (2018)](https://pubmed.ncbi.nlm.nih.gov/29476743/)

[Nakanishi et al., GPI-anchored protein deficiency in models of neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31195012/)

[Tashima et al., Molecular characterization of PGAP2 in lipid raft formation (2016)](https://pubmed.ncbi.nlm.nih.gov/27053577/)

[Yanai et al., Therapeutic targeting of GPI biosynthesis enzymes (2019)](https://pubmed.ncbi.nlm.nih.gov/31229876/)

[Morita et al., ER-to-Golgi trafficking of GPI-anchored proteins (2019)](https://pubmed.ncbi.nlm.nih.gov/30670488/)

[Kikuchi et al., GPI anchor remodeling in aging and age-related neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31247367/)

[Yao et al., Lipid composition changes in substantia nigra in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31184567/)

[Takeda et al., Molecular pathology of hereditary spastic paraplegia (2018)](https://pubmed.ncbi.nlm.nih.gov/29482105/)

[Kawaguchi et al., GPI-anchored protein disorders in neurological diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

📖 View canonical wiki page →

Related Entities

PGAP2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-pgap2
kg_node_id	PGAP2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9c72f7b64b55
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-pgap2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PGAP2

PGAP2 — Post-GPI Attachment to Proteins 2

Overview

Gene Information

Protein Structure and Function

GPI Anchor Biology

PGAP2 — Post-GPI Attachment to Proteins 2

Overview

Gene Information

Protein Structure and Function

GPI Anchor Biology

GPI Anchor Architecture

PGAP2 Enzymatic Function

1. Lipid Remodeling

2. Flippase Activity

Structure-Function Relationships

GPI Anchor Remodeling Pathway

Biosynthetic Cascade

PGAP2 in the Context of Other PGAPs

Role in Neurodegeneration

Hereditary Spastic Paraplegia

Mechanisms of Neurodegeneration

1. GPI-Anchored Protein Dysfunction

2. Membrane Microdomain Abnormalities

3. Synaptic Dysfunction

Axonal Degeneration

GPI-Anchored Proteins in the Brain

Critical Neuronal Functions

Synaptic Proteins

Signaling Receptors

Adhesion Molecules

Enzymes

Aging and GPI Anchor Biology

Age-Related Changes

Implications for Age-Related Neurodegeneration

Alzheimer's Disease Connections

Prion Protein Interactions

Membrane Microdomain Dysfunction

Therapeutic Implications

Parkinson's Disease Connections

Membrane Lipid Alterations

Alpha-Synuclein Interactions

Therapeutic Implications

Small Molecule Approaches

Enzyme Stabilizers

Lipid Raft Modulators

Gene Therapy Strategies

Challenges

Expression Pattern

Tissue Distribution

Cellular Localization

Developmental Expression

Molecular Mechanisms

ER Quality Control

Protein Trafficking

Lipid Raft Formation

Research Models

Cellular Models

Animal Models

Biochemical Studies

Diagnostic Significance

Genetic Testing

Biomarkers

Cross-Linking to Related Topics

Diseases

Proteins and Pathways

Related Genes

Summary

See Also

External Links

References

💬 Discussion